The American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) have recently released new joint guidelines that outline best practices for the management of psoriasis (PsO) with biologics, the need for awareness and attention to comorbidities, and guidelines for pediatric PsO treatment. Clinicians must ensure that they are aware of these guidelines and of strategies to incorporate them into clinical practice, including the integration of biologic therapy into treatment plans, the implementation of strategies to manage comorbidities, and the management of pediatric patients with PsO, in alignment with guideline recommendations.
In this interactive CMEO Live and On Demand webcast, leading experts in PsO will utilize clinical cases to illustrate real-life approaches that learners can apply in order to optimize incorporation of these latest recommendations into clinical practice.
Learning Objectives
At the end of this CE activity, participants should be able to:
-Integrate biologic therapy into treatment plans for appropriate patients with moderate-to-severe PsO, in accordance with the joint AAD-NPF guidelines.
-Implement strategies to manage comorbidities in patients with PsO as recommended by the joint AAD-NPF guidelines.
-Apply the joint AAD-NPF guidelines when managing pediatric patients with PsO.
The following learning objectives pertain only to those requesting CNE or CPE credit:
-Describe treatment plans for appropriate patients with moderate-to-severe PsO in accordance with the joint AAD-NPF guidelines.
-Explain strategies to manage comorbidities in patients with PsO, as recommended by the joint AAD-NPF guidelines.
-Identify the joint AAD-NPF guidelines when managing pediatric patients with PsO.
